February 3, 2016

GOG-0281: Temporary Accrual Suspension due to acute shortage of Trametinib.

CTEP has required the immediate suspension of accrual to GOG-0281 as of February 2, 2016 at 5 p.m. ET due to an acute shortage in the supply of Trametinib. Please see the 0281 protocol page on the GOG legacy website for a memo with more details.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103